Adeno-associated virus compositions having increased brain enrichment
AssigneeCapsida, Inc.
InventorsNicholas C. Flytzanis, Nicholas S. Goeden, Troy E. Sandberg, Brandon G. Wheeler
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and kits comprising recombinant adeno-associated viruses (rAAVs) with increased transduction enrichment in the CNS. The rAAV compositions described herein encapsidate a transgene, such as a therapeutic nucleic acid. Gene therapy using the rAAVs is described. Also described are methods of treating CNS-related diseases and conditions.
Claims50
An AAV capsid protein comprising a sequence as provided in Table 1 or FIG. 1.
An AAV capsid comprising an insertion sequence of Formula I
- (I)
- (SEQ ID NO:
- 2)
- X1-N-X2-X3-X4-X5-X6
- wherein X1 is an amino acid selected from A, S, G, N, L, Y, H, D, E, Q, P, T and V;
- X2 is an amino acid selected from Q, S, V, T, N, H and A;
- X3 is an amino acid selected from I, V and T;
- X4 is an amino acid selected from K and R;
- X5 is an amino acid selected from N, V, P, I, T, S, Q, A, L and G;
- and X6 is an amino acid selected from I, S, T, L, V, M, Y, F, A and N.
An AAV capsid protein comprising an insertion sequence of Formula II
- (II)
- (SEQ ID NO:
- 3)
- X7-N-H-V-R-X8-X9
- wherein X7 is an amino acid selected from A, S, G, N, L, Y, H, D, E, Q, P, T and V;
- X8 is an amino acid selected from N, V, P, I, T, S, Q, A, L and G;
- and X9 is an amino acid selected from I, S, T, L, V, M, Y, F, A and N.
An AAV capsid protein comprising an AAV capsid protein comprising an insertion sequence of Formula III
- (III)
- (SEQ ID NO:
- 4)
- X10-N-V-X11-X12-X13-X14
- wherein X10 is an amino acid selected from A, S, G, N, L, Y, H, D, E, Q, P, T and V;
- X11 is an amino acid selected from V and T;
- X12 is an amino acid selected from K and R;
- X13 is an amino acid selected from N, V, P, I, T, S, Q, A, L and G;
- and X4 is an amino acid selected from I, S, T, L, V, M, Y, F, A and N.
An AAV capsid protein comprising an AAV capsid protein comprising an insertion sequence of Formula IV
- (IV)
- (SEQ ID NO:
- 5)
- X15-N-T-X16-X17-X18-X19
- wherein X15 is an amino acid selected from A, S, G, N, L, Y, H, D, E, Q, P, T and V;
- X16 is an amino acid selected from I, V and T;
- X17 is an amino acid selected from K and R;
- X1a is an amino acid selected from N, V, P, I, T, S, Q, A, L and G;
- and X19 is an amino acid selected from I, S, T, L, V, M, Y, F, A and N.
An AAV capsid protein comprising an AAV capsid protein comprising an insertion sequence of Formula V
- (V)
- (SEQ ID NO:
- 6)
- X20-N-X21-V-R-X22-X23
- wherein X20 is an amino acid selected from A, S, G, N, L, Y, H, D, E, Q, P, T and V;
- X21 is an amino acid selected from Q, S, V, T, N, H and A;
- X22 is an amino acid selected from N, V, P, I, T, S, Q, A and L;
- and X23 is an amino acid selected from I, S, T, L, V, M, Y, F and A.
An AAV capsid protein comprising an AAV capsid protein comprising an insertion sequence of Formula VI
- (VI)
- (SEQ ID NO:
- 7)
- X24-N-X25-T-K-X26-X27
- wherein X24 is an amino acid selected from A, S, L, N, H, D, E, P, T and V;
- X25 is an amino acid selected from Q, S, V, T and N;
- X26 is an amino acid selected from N, V, P, T, S, Q and G;
- and X27 is an amino acid selected from I, S, T, L, V, M, Y, F, A and N.
An AAV capsid protein comprising an insertion sequence of Formula VII
- (VII)
- (SEQ ID NO:
- )
- X28-N-X29-T-R-X30-X31
- wherein X28 is an amino acid selected from A, S, G, N, L, H, P, T and V;
- X29 is an amino acid selected from Q, S, V, T and H;
- X30 is an amino acid selected from N, V, T, S, Q, L and G;
- and X31 is an amino acid selected from I, S, T, V, M, Y, F, A and N.
A nucleic acid sequence encoding a peptide sequence as provided in Table 1 or FIG. 1.
A peptide comprising an amino acid sequence selected from GNTTRVT (SEQ ID NO:
- 9), LNSVRNT (SEQ ID NO:
- 10), NNNTKPS (SEQ ID NO:
- 11), GNSIKVV (SEQ ID NO:
- 12), GNSVRIS (SEQ ID NO:
- 13), ENHVRSS (SEQ ID NO:
- 14), SNTTRQT (SEQ ID NO:
- 15), TNSVKAT (SEQ ID NO:
- 16), GNTTRLV (SEQ ID NO:
- 17), SNSVRLV (SEQ ID NO:
- 18), ENSTKSL (SEQ ID NO:
- 19), ANSTRTT (SEQ ID NO:
- 20), PNQTRNN (SEQ ID NO:
- 21), QNSVKGY (SEQ ID NO:
- 22), GNHVRLA (SEQ ID NO:
- 23), VNSTKST (SEQ ID NO:
- 24), and DNSIRSS (SEQ ID NO:
- 25).
A recombinant adeno-associated virus (rAAV) comprising a capsid comprising any one of GNTTRVT (SEQ ID NO:
- 9), LNSVRNT (SEQ ID NO:
- 10), NNNTKPS (SEQ ID NO:
- 11), GNSIKVV (SEQ ID NO:
- 12), GNSVRIS (SEQ ID NO:
- 13), ENHVRSS (SEQ ID NO:
- 14), SNTTRQT (SEQ ID NO:
- 15), TNSVKAT (SEQ ID NO:
- 16), GNTTRLV (SEQ ID NO:
- 17), SNSVRLV (SEQ ID NO:
- 18), ENSTKSL (SEQ ID NO:
- 19), ANSTRTT (SEQ ID NO:
- 20), PNQTRNN (SEQ ID NO:
- 21), QNSVKGY (SEQ ID NO:
- 22), GNHVRLA (SEQ ID NO:
- 23), VNSTKST (SEQ ID NO:
- 24), and DNSIRSS (SEQ ID NO:
- 25).
Dependencies are inferred from the claim text.